Mastermind-like 1 is a specific coactivator of β-catenin transcription activation and is essential for colon carcinoma cell survival

被引:79
作者
Alves-Guerra, Marie-Clotilde
Ronchini, Chiara
Capobianco, Anthony J.
机构
[1] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA
[2] Inst Europeo Oncol, Milan, Italy
关键词
D O I
10.1158/0008-5472.CAN-07-1720
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Misregulation of the Wnt signaling pathway has been linked to many human cancers including colon carcinoma and melanoma. The primary mediator of the oncogenic effects of the Wnt signaling pathway is beta-catenin. Accumulation of nuclear beta-catenin and transcription activation of lymphoid enhancer factor 1 (LEF1)/T-cell factor (TCF) target genes underlie the oncogenic activity. However, the mechanism of beta-catenin-mediated transcriptional activation remains poorly understood. In this study, we identified Mastermind-like I (Maml1), which is thought to be a specific coactivator for the Notch pathway.. as a coactivator for beta-catenin. We found that Maml1 participates in the Writ signaling by modulating the beta-catenin/TCF activity. We show in vivo that Maml1 is recruited by beta-catenin on the cyclin DI and c-Myc promoters. Importantly, we show that Maml1 functions in the Wnt/beta-catenin pathway independently of Notch signaling. Finally, we show that the knockdown of Mastermind-like family proteins in colonic carcinoma cells results in cell death by affecting beta-catenin-induced expression of cyclin DI and c-Myc. This is the first demonstration of a role for the Mastermind-like family in another signaling pathway and that the knockdown of Mastermind-like family function leads to tumor cell death.
引用
收藏
页码:8690 / 8698
页数:9
相关论文
共 28 条
[1]   Nuclear endpoint of Wnt signaling: Neoplastic transformation induced by transactivating lymphoid-enhancing factor 1 [J].
Aoki, M ;
Hecht, A ;
Kruse, U ;
Kemler, R ;
Vogt, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :139-144
[2]  
Arber N, 1997, CANCER RES, V57, P1569
[3]   The chromatin remodelling factor Brg-1 interacts with β-catenin to promote target gene activation [J].
Barker, N ;
Hurlstone, A ;
Musisi, H ;
Miles, A ;
Bienz, M ;
Clevers, H .
EMBO JOURNAL, 2001, 20 (17) :4935-4943
[4]   THE PRAD-1 CYCLIN D1 ONCOGENE PRODUCT ACCUMULATES ABERRANTLY IN A SUBSET OF COLORECTAL CARCINOMAS [J].
BARTKOVA, J ;
LUKAS, J ;
STRAUSS, M ;
BARTEK, J .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (04) :568-573
[5]   Essential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functions [J].
Brembeck, FH ;
Schwarz-Romond, T ;
Bakkers, J ;
Wilhelm, S ;
Hammerschmidt, M ;
Birchmeier, W .
GENES & DEVELOPMENT, 2004, 18 (18) :2225-2230
[6]   Mastermind recruits CycC:CDK8 to phosphorylate the notch ICD and coordinate activation with turnover [J].
Fryer, CJ ;
White, JB ;
Jones, KA .
MOLECULAR CELL, 2004, 16 (04) :509-520
[7]   Distinct molecular forms of β-catenin are targeted to adhesive or transcriptional complexes [J].
Gottardi, CJ ;
Gumbiner, BM .
JOURNAL OF CELL BIOLOGY, 2004, 167 (02) :339-349
[8]   Adhesion signaling:: How β-catenin interacts with its partners [J].
Gottardi, CJ ;
Gumbiner, BM .
CURRENT BIOLOGY, 2001, 11 (19) :R792-R794
[9]   Wnt signaling in the intestinal epithelium: from endoderm to cancer [J].
Gregorieff, A ;
Clevers, H .
GENES & DEVELOPMENT, 2005, 19 (08) :877-890
[10]   The p300/CBP acetyltransferases function as transcriptional coactivators of β-catenin in vertebrates [J].
Hecht, A ;
Vleminckx, K ;
Stemmler, MP ;
van Roy, F ;
Kemler, R .
EMBO JOURNAL, 2000, 19 (08) :1839-1850